Results 71 to 80 of about 8,451 (217)
Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune Vasculitis
Objective Immune checkpoint inhibitors (ICIs) are effective cancer therapies but often cause serious immune‐related adverse events (irAEs). Patients with preexisting autoimmune diseases, including vasculitis, are excluded from trials. We aimed to evaluate the frequency, severity, and outcomes of vasculitis flares and irAEs in this population.
Juan Sevillano +4 more
wiley +1 more source
ABSTRACT Background Hidradenitis suppurativa (HS) remains a therapeutically challenging disease despite expanding research and evolving systemic treatments. Energy‐based modalities, such as fractional microneedling radiofrequency (FMR), are being increasingly explored as novel treatment options.
Ari Safir +7 more
wiley +1 more source
Diagnostic challenge of intestinal obstruction secondary to Henoch–Schonlein purpura [PDF]
Henoch–Schonlein purpura is the most common form of vasculitis in pediatric age group. Gastrointestinal manifestations have been long recognized as part of the disease, but usually preceded by other manifestations.
Ahmed, Ali M. +2 more
core +2 more sources
Successful Treatment of Severe Purpura Fulminans With Anakinra
ABSTRACT Purpura fulminans (PF) is a rare, often fatal pediatric condition characterized by intravascular thrombosis and hemorrhagic infarction of the skin. A timely diagnosis and treatment are paramount to prevent the involvement of internal organs, causing disseminated intravascular coagulation and gangrene of the extremities.
Francesco Zulian +4 more
wiley +1 more source
Increased Serum Interleukin-17 and Peripheral Th17 Cells in Children with Acute Henoch-Schonlein Purpura [PDF]
Background: Interleukin (IL)-17 and Th17 cells have been involved in many autoimmune diseases. The aim of this study is to investigate the involvement of IL-17 and Th17 cells in the pathogenesis of childhood Henoch-Schonlein purpura (HSP ).
JEN, HSIAO-YU;CHUANG, YA-HUI;LIN, SHENG-CHIEH;CHIANG, BOR-LUEN;YANG, YAO-HSU +1 more
core
Association of Mycoplasma Pneumoniae Infection with Henoch-Schonlein Purpura [PDF]
We present a child with Henoch-Schonlein purpura and Mycoplasma pneumoniae infection, an association that was rarely described in the literature.
Sharifi, Fariba +9 more
core +1 more source
Henoch-Schönlein purpura (HSP) also known as IgA vasculitis is a systemic small vessel vasculitis mainly affecting the skin, kidneys, joints, and gastrointestinal tract. However, the disease can affect any organ system of the body. The classic tetrad of
Muhammad Tahir +3 more
doaj +1 more source
Risk Factors of Disease Progression in IgA Nephropathy: A Systematic Review and Meta‐Analysis
ABSTRACT Objective IgA nephropathy (IgAN) is an important cause of chronic renal failure, and nearly all patients with IgAN are at risk of developing to end‐stage renal disease (ESRD) during their lifetime. This meta‐analysis aimed to identify and evaluate risk factors associated with the progression of IgAN patients.
Dan Xu +4 more
wiley +1 more source
Henoch–Schonlein purpura antecedent to Crohn’s disease [PDF]
We report a 13-year-old youth who initially presented with the typical rash of Henoch–Schonlein purpura followed a month later by a nephrotic syndrome and hematuria. Renal biopsy revealed crescentic IgA nephropathy.
Tania Zehavi +4 more
core +1 more source
Abstract Background Studies suggest an increase in autoimmune diseases following SARS‐CoV‐2 infection and/or COVID‐19‐vaccination. We aimed to describe possible associations in Norway. Methods We used information from the emergency preparedness register for COVID‐19, BeredtC19, for all residents aged 18–64 (N = 3,450,080).
Håkon Bøås +4 more
wiley +1 more source

